How does a widely used once-weekly diabetes medication affect blood sugar, stomach emptying, and post-meal blood pressure?
About the study
We are conducting a research study to understand how a widely used once-weekly medication affects blood sugar control in people with type 2 diabetes. This medication may lower post-meal blood sugar by slowing stomach emptying, but its precise effects have not yet been measured using the gold standard technique, scintigraphy. By participating, you can help us measure how the medication affects stomach emptying, explore the link between stomach-emptying rate and post-meal blood pressure, and determine how long these effects last after stopping the medication. The study runs for 16 weeks, including three full study days (approx. five hours each) and short weekly visits (approx. 30 minutes) to receive the medication.
Eligibility requirements
You may be eligible to participate in this study if you:
- Are aged between 40 and 85 years
- Have type 2 diabetes
- Manage diabetes with diet and/or metformin only.
Study participants must be able to attend the Clinical Research Facility at the Adelaide Health and Medical Sciences Building on North Terrace.
Recruitment timeline
Start of recruitment: Jan 2025
End of recruitment: Dec 2026
Benefits
Participation involves approximately 30 hours over the 16 week study. Volunteers will receive an honorarium of up to $700 upon completing the study, paid according to ethical committee approval.
To register your interest in taking part in this study, please contact the Study Coordinator on +61 402 593 400 or at researchdiabetes@adelaide.edu.au.
